SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

InMed Pharmaceuticals Reports Q1 FY2027 Net Loss of $2.33 Million

InMed Pharmaceuticals said cash is expected to fund operations into mid-November.

INM

Story updates

09:59:14 PM UTC
SquawkNews
Canada's InMed Pharmaceuticals Q1 loss widens Overview Canada pharmaceutical developer's fiscal Q1 n
09:59:18 PM UTC
SquawkNews
Canada's InMed Pharmaceuticals Q1 loss widens

InMed Pharmaceuticals reported a $2.33 million first-quarter fiscal 2027 net loss and said its cash is expected to fund operations into mid-November.Key Highlights:Original SEC Filing: InMed Pharmaceuticals Inc. [ INM ] - 8-K - Nov. 03, 2026This is an AI-powered summary. It may contain inaccuracies…

Related stories